Trial · NCT02814565
Results by group216
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 216
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Day 3 of Treatment | Cyclobenzaprine HCl 15 mg | Day 3, 0=poor | 20.0 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Day 3 of Treatment | Placebo | Day 3, 0=poor | 28.9 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Day 3 of Treatment | Cyclobenzaprine HCl 15 mg | Day 3, 1=fair | 60.0 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Day 3 of Treatment | Placebo | Day 3, 1=fair | 46.7 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Day 3 of Treatment | Cyclobenzaprine HCl 15 mg | Day 3, 2=good | 16.7 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Day 3 of Treatment | Placebo | Day 3, 2=good | 22.2 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Day 3 of Treatment | Cyclobenzaprine HCl 15 mg | Day 3, 3=very good | 3.3 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Day 3 of Treatment | Placebo | Day 3, 3=very good | 2.2 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Day 3 of Treatment | Cyclobenzaprine HCl 15 mg | Day 3, 4=excellent | 0.0 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Day 3 of Treatment | Placebo | Day 3, 4=excellent | 0.0 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Days 7 and 14 of Treatment | Cyclobenzaprine HCl 15 mg | Day 7, 0=poor | 7.8 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Days 7 and 14 of Treatment | Placebo | Day 7, 0=poor | 16.7 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Days 7 and 14 of Treatment | Cyclobenzaprine HCl 15 mg | Day 7, 1=fair | 41.1 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Days 7 and 14 of Treatment | Placebo | Day 7, 1=fair | 34.4 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Days 7 and 14 of Treatment | Cyclobenzaprine HCl 15 mg | Day 7, 2=good | 35.6 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Days 7 and 14 of Treatment | Placebo | Day 7, 2=good | 34.4 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Days 7 and 14 of Treatment | Cyclobenzaprine HCl 15 mg | Day 7, 3=very good | 13.3 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Days 7 and 14 of Treatment | Placebo | Day 7, 3=very good | 11.1 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Days 7 and 14 of Treatment | Cyclobenzaprine HCl 15 mg | Day 7, 4=excellent | 2.2 | percentage of participants | |
| Percentage of Participants With Subject's Rating of Medication Helpfulness Impression on Days 7 and 14 of Treatment | Placebo | Day 7, 4=excellent | 3.3 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02814565/results